GNH USA

Europe — EMA

Imovax D.T. Adult

GNH USA supplies Imovax D.T. Adult (Diphtheria/Tetanus), a vaccine for prevention of diphtheria and tetanus in adults. Request a quote for global supply.

Diphtheria Toxoid, Tetanus Toxoid, Algeldrate

Request sourcing

1
Pack/s

What is Diphtheria Toxoid, Tetanus Toxoid, Algeldrate?

Diphtheria Toxoid, Tetanus Toxoid, Algeldrate, the active ingredient in Imovax D.T. Adult, is a vaccine presented as an injectable solution for intramuscular/subcutaneous use. It prevents diphtheria and tetanus in adults.

GNH USA supplies Imovax D.T. Adult as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Diphtheria Toxoid, Tetanus Toxoid, Algeldrate used for?

Imovax D.T. Adult is a diphtheria‑tetanus toxoid vaccine used for immunization against bacterial toxin‑mediated diseases.

- Diphtheria: provides active immunity against diphtheria toxin in adults. - Tetanus: provides active immunity against tetanus toxin in adults. - Booster immunization: restores waning immunity to diphtheria and tetanus in previously vaccinated adults.

What are the side effects of Diphtheria Toxoid, Tetanus Toxoid, Algeldrate?

Common Side Effects: - Pain at the injection site - Redness or swelling at the injection site - Mild fever - Headache - Fatigue - Nausea

Serious or Rare Side Effects: - Anaphylactic reaction (severe allergic response) - Guillain‑Barré syndrome - Seizures - High‑grade fever - Prolonged or extensive swelling - Neurologic disorders such as encephalopathy

What precautions apply to Diphtheria Toxoid, Tetanus Toxoid, Algeldrate?

Imovax D.T. Adult should be administered only after evaluating patient history.

- Screen for hypersensitivity: avoid in individuals with known allergy to any vaccine component. - Assess immunization history: ensure appropriate interval since previous diphtheria/tetanus vaccination. - Pregnancy considerations: use only if benefits outweigh risks, after consulting a healthcare provider. - Concurrent immunizations: may be given with other vaccines at separate anatomical sites. - Immunocompromised patients: immune response may be reduced; monitor antibody levels. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Diphtheria Toxoid, Tetanus Toxoid, Algeldrate interact with?

Imovax D.T. Adult may interact with other agents that affect immune response.

Major Interactions (Avoid): - Live vaccines: concurrent administration may reduce efficacy of the live vaccine. - Immunoglobulin therapy: may interfere with vaccine‑induced immunity if given within 2 weeks. - Blood products: may diminish vaccine‑induced immunity if administered within 4 weeks.

Moderate Interactions (Monitor Closely): - Antipyretics: may mask fever but are generally safe. - High‑dose corticosteroids: can blunt the immune response to the vaccine. - Immunosuppressive antibiotics: generally no effect, but monitor in heavily immunosuppressed patients.

Frequently asked questions

What is Imovax D.T. Adult used for?+
Imovax D.T. Adult is a diphtheria‑tetanus toxoid vaccine indicated for the active immunization of adults against diphtheria and tetanus. It is used both for primary vaccination in previously unvaccinated adults and as a booster to maintain protective immunity in those who have completed an earlier vaccination schedule.
How does diphtheria and tetanus toxoid work?+
The vaccine contains chemically inactivated forms of the diphtheria and tetanus toxins (toxoids). When injected, these toxoids are recognized as foreign by the immune system, prompting B‑cells to produce specific antibodies. The aluminum‑based adjuvant algeldrate amplifies this response, ensuring a strong and lasting protective immunity against the natural toxins.
What is the usual dose of Imovax D.T. Adult?+
The exact dose and schedule are determined by the prescribing healthcare professional. Typically, a single intramuscular or subcutaneous injection is administered for primary immunization, with booster doses given at recommended intervals to sustain immunity. Specific dosing may vary based on prior vaccination history and local guidelines.
Is Imovax D.T. Adult safe during pregnancy or breastfeeding?+
Safety data for use during pregnancy and lactation are limited. The vaccine should only be administered when the potential benefit to the mother outweighs any theoretical risk to the fetus or infant. Healthcare providers should evaluate each case individually and discuss any concerns with the patient.
How do I order Imovax D.T. Adult from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity of Imovax D.T. Adult. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain logistics), and necessary import documentation.
How does Imovax D.T. Adult compare with other diphtheria‑tetanus vaccines?+
Imovax D.T. Adult uses the same diphtheria and tetanus toxoid antigens found in other licensed vaccines, with algeldrate as an aluminum‑based adjuvant to boost immune response. Clinical efficacy and safety profiles are comparable to other EU‑approved diphtheria‑tetanus vaccines, though formulation differences such as adjuvant type may influence reactogenicity in some individuals.
How should Imovax D.T. Adult be stored and handled?+
The vaccine must be stored at 2‑8 °C (refrigerated). It should be kept in the original packaging, protected from light, and must never be frozen or shaken. During transport, maintain the cold‑chain conditions to preserve potency, and discard any vial that has been exposed to temperatures outside the recommended range.
How is Imovax D.T. Adult administered?+
Imovax D.T. Adult is administered by a single intramuscular or subcutaneous injection, usually into the deltoid muscle of the upper arm or the anterolateral thigh in adults. The injection site should be cleaned with an antiseptic, and the volume is drawn into a sterile syringe according to the vial’s labeling.
What are the most serious risks associated with Imovax D.T. Adult?+
Serious adverse events are rare but may include severe allergic reactions such as anaphylaxis, Guillain‑Barré syndrome, seizures, and high‑grade fever. Any signs of a severe reaction—such as difficulty breathing, swelling of the face or throat, or neurological symptoms—require immediate medical attention.
Who should not receive Imovax D.T. Adult?+
Individuals with a known severe allergy to any component of the vaccine, including the toxoids or the algeldrate adjuvant, should not receive it. It is also contraindicated in persons who have experienced a serious immediate hypersensitivity reaction to a previous dose of a diphtheria‑tetanus vaccine.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Diphtheria Toxoid, Tetanus Toxoid, Algeldrate
Route
Intramuscular Use , Subcutaneous Use
Manufacturer
Sanofi Winthrop Industrie
Origin
EU

Related products